Providers

James Orsini, Jr., MD

Dr. James Orsini, Jr.

Fellowship

Hematology/Oncology, Newark Beth Israel Medical Center, Newark, NJ

Residency

Internal Medicine, New York University Langone Medical Center, New York, NY

MD

St. George University School of Medicine, Grenada

Member

American Society of Clinical Oncology, American Society of Hematology, American Society of Urological Oncology, American College of Physicians

Awards

Named one of New Jersey’s Top Doctors

new jersey top doctor 2023

 

In The News

Dr. Orsini Jr. has been named a 2023 Jersey Choice Top Doctor!

View Full Article

Dr. Orsini Jr  was recently featured in an article called “A Handle on Prostate Health.” View the article on the six signs of a prostate problem and what they might mean.

View Full Article


James Orsini, Jr., MD followed his father into a career of service to others as a physician and cancer specialist. Before going into oncology and hematology, Dr. Orsini completed his residency training in internal medicine at New York University Langone Medical Center in New York City. After that, he went on to complete fellowship training in hematology/oncology at Newark Beth Israel Medical Center.

He currently specializes in Genitourinary malignancies and works with a large urology group, consulting and collaborating with them on all phases of diagnosis, research, and the very latest treatment options.

In addition to his training and experience as a cancer and blood-disorders specialist, Dr. Orsini brings to New Jersey Cancer Care a broad perspective from his experiences as an internal medicine specialist and as a hospitalist. In 2010, he was elected to be a House Staff Council member at NYU’s School of Medicine.

In 2014 he became co-chief fellow at NBI; in 2016 he was elected to the Commission on Cancer at Clara Mass Medical Center; in 2018 he was awarded Top Doctor designation in NJ by his peers, and then again in 2019.

Dr. Orsini also initiated a robust research program at New Jersey Cancer Care and has been the primary investigator on 9 open trials while spearheading the ongoing expansion of the program.

Dr. Orisini speaks both English and Italian.

Locations